CELEX: 21990A0320(04)
Language: en
Date: 1990-02-26 00:00:00
Title: Cooperation Agreement between the European Economic Community and the Kingdom of Sweden in the field of medical and health research

Avis juridique important

|

21990A0320(04)

Cooperation Agreement between the European Economic Community and the Kingdom of Sweden in the field of medical and health research  

Official Journal L 074 , 20/03/1990 P. 0027

COOPERATION AGREEMENT between the European Economic Community and the Kingdom of Sweden in the field of medical and health research THE EUROPEAN ECONOMIC COMMUNITY,  hereinafter referred to as 'the Community', and THE KINGDOM OF SWEDEN,  hereinafter referred to as 'Sweden',  both hereinafter referred to as 'the Contracting Parties',  WHEREAS the Contracting Parties concluded a Framework Agreement for Scientific and Technical Cooperation which entered into force on 27 August 1987;  WHEREAS by its Decision of 17 November 1987, the Council of the European Communities, hereinafter referred to as 'the Council', adopted a research and development coordination programme of the Community in the field of medical and health research (1987  to 1991);  WHEREAS comprehensive research and development activities in the field of medical and health research are carried out in Sweden;  WHEREAS cooperation in the field of medical and health research is likely to contribute effectively to the attainment of an optimum level of individual and public health;  WHEREAS the Member States of the Community and Sweden intend, in accordance with the rules and procedures applicable to their national programmes, to carry out the research described in Annex A and are prepared to integrate such research into a process  of coordination which they consider will be of mutual benefit,  HAVE AGREED AS FOLLOWS:    Article 1 The Contracting Parties shall cooperate for a period from 1 January 1988 to 31 December 1991 in the research targets and areas of the Community programme outlined in Annex A.  The cooperation shall consist of the coordination of those activities which form part of the research programmes of Sweden and of the Communtiy.  Sweden and the Member States of the Community shall remain entirely responsible for the research carried out by their national institutions or bodies.  Article 2 The Commission of the European Communities, hereinafter referred to as 'the Commission', shall be responsible for the implementation of the coordination activities.  It shall be assisted in its task by the Management and Coordination Advisory Committee on Medical and Health Research, hereinafter referred to as the 'CGC', set up by Council Decision 84/338/Euratom, ECSC, EEC. This CGC may be assisted by concerted  action committees (COMACs) composed of experts designated by the competent authorities of Member States of the Community.  The CGC, together with those COMACs relevant to the research targets referred to in Article 1, shall be enlarged to include two representatives designated by Sweden who may be assisted or replaced by one Swedish expert. These representatives and/or  experts shall attend meetings of the CGC and those COMACs for all items relevant to those research targets and areas.  Article 3 The estimated financial contribution from the Community for the implementation of the coordination activities covered by this Agreement shall be set according to the amount available each year in the general budget of the European Communities for appropriations covering commitments to meet the financial obligations of the Commission relating to coordination costs,  management and operating expenditure and fellowships.  The estimated financial contribution from Sweden for the same costs and expenditure shall be proportional to the Community's contribution. The proportionality factor shall be given by the ratio between Sweden's gross domestic product (GDP) at market  prices and the sum of gross domestic products at market prices of the Member States of the Community and Sweden. This ratio shall be calculated on the basis of the latest available OECD statistical data.  The total financial contributions from the Contracting Parties for the periods referred to in Article 1 are estimated to amount to:  - ECU 40 570 000 from the Community,  - ECU 1 488 919 from Sweden.  The ecu is that defined by Council Regulation (EEC) No 3180/78 of 18 December 1978 changing the value of the unit of account used by the European Monetary Cooperation Fund, as amended by Regulation (EEC) No 2626/84.  The rules governing the financial contribution from Sweden are set out in Annex B.  Article 4 During the course of its third year, the Commission shall evaluate the programme, having regard to the objectives of the research targets referred to in Article 1. As a result of this evaluation, the Commission may, after the CGC has been  consulted, submit to the Council a proposal for a revision affecting some or all of the research targets. Sweden shall be informed of the results of this evaluation and of any possible revision.  Article 5 The Member States of the Community, Sweden and the Commission shall regularly exchange all useful information concerning the execution of the research subjects covered by this Agreement. The Member States of the Community and Sweden shall  provide the Commission with all information necessary for coordination purposes. They shall also endeavour to provide the Commission with information on similar research planned or carried out by bodies which are not under their authority. Any  information shall be treated as confidential if so requested by the party which provides it.  On completion of the coordination activities covered by this Agreement, the Commission, in agreement with the CGC, shall send to the Member States of the Community, the European Parliament and Sweden a summary report on the implementation and results of  the research.  Article 6 This Agreement shall apply, on the one hand, to the territories in which the Treaty establishing the European Economic Community is applied and under the conditions laid down in that Treaty and, on the other hand, to the territory of the  Kingdom of Sweden.  Article 7 This Agreement shall be approved by the Contracting Parties in accordance with their existing procedures. It shall enter into force on the date on which the Contracting Parties have notified each other of the completion of the procedures  necessary for this purpose.  Article 8 1.  This Agreement is hereby concluded for the period referred to in Article 1.  Should the Community revise the Community programme, the Agreement may be terminated in the month following the Community decision. The Contracting Party wishing to terminate the Agreement shall give written notice to the other Contracting Party of its  decision. The Agreement shall terminate on the date of receipt of the written notice by the other Contracting Party.  2.  Whenever a decision on the Community programme is taken by the Community, Annexes A and B shall be amended in accordance with the Community's decision, unless otherwise agreed upon by the Contracting Parties.  3.  Save as provided in paragraph 1, either Contracting Party may at any time give written notice to the other Contracting Party of its decision to terminate this Agreement. The Agreement shall terminate six months after the date of receipt of the  written notice by the other Contracting Party.  Article 9 Annexes A and B to this Agreement shall form an integral part thereof.  Article 10 This Agreement shall be drawn up in duplicate in the Danish, Dutch, English, French, German, Greek, Italian, Portuguese and Spanish languages, each of these texts being equally authentic.    ANNEX A   RESEARCH TOPICS COVERED BY THE AGREEMENT    Target I.1 - Cancer Area I.1.2: Clinical treatment research Area I.1.3: Epidemiological research Area I.1.4: Early detection and diagnosis Area I.1.5: Drug development   Target I.2 - AIDS Area I.2.1: Disease control and prevention Area I.2.2: Viro-immunological research Area I.2.3: Clinical research   Target I.3 - Age-related health problems Area I.3.2: Ageing and disease Area I.3.3: Disabilities   Target I.4 - Environment and life-style related health problems Area I.4.2: Nutrition   Target II.1 - Medical technology development Area II.1.1: Diagnostic methods and monitoring Area II.1.2: Treatment and rehabilitation Area II.1.3: Technical and clinical evaluation   ANNEX B FINANCING RULES  Article 1 These provisions lay down the financing rules for Sweden referred to in Article 3 of the Agreement.  Article 2 At the beginning of each year, or - in accordance with Article 8 of the Agreement - whenever the Community programme is revised so as to involve an increase in the amount estimated to be necessary for its implementation, the Commission shall send to  Sweden a call for funds corresponding to its share of the annual costs under the Agreement.  This contribution shall be expressed both in ecus and in Swedish currency. The value in Swedish currency of the contribution in ecus shall be determined on the date of the call for funds.  The travel costs of Swedish representatives and experts arising from their participation in the work of the CGC and COMACs referred to in Article 2 of the Agreement, shall be reimbursed by the Commission in accordance with the procedures currently in  force for the representatives and experts of the Member States of the Community and, in particular, in accordance with Council Decision 84/338/Euratom, ECSC, EEC.  Sweden shall pay its contribution to the annual costs under the Agreement at the beginning of each year and at the latest three months after the call for funds is sent. Any delay in the payment of the contribution shall give rise to the payment of  interest by Sweden at a rate equal to the highest discount rate in force in the Member States of the Community on the due date. The rate shall be increased by 0,25 of a percentage point for each month of delay.  The increased rate shall be applied to the entire period of delay. However, this interest shall be payable only if the contribution is paid more than three months after a call for funds has been made by the Commission.  Article 3 The funds paid by Sweden shall be credited to the three research targets as budget receipts allocated to an appropriate heading in the statement of revenue of the general budget of the European Communities.  Article 4 The provisional timetable for the costs referred to in Article 3 of the Agreement is appended hereto.  Article 5 The Financial Regulations in force applicable to the general budget of the European Communities shall apply to the management of the appropriations.  Article 6 At the end of each year, a statement of appropriations for the three research targets shall be prepared and transmitted to Sweden for information.